• Radioiodinated Balsalazide as a Selective Tracer for Ulcerat

  2026-05-11

  This study introduces a highly selective radioiodinated balsalazide tracer for imaging ulcerative colitis in mice, achieving high labeling yield and stability for prolonged organ tracking. The findings address gaps in previous radiotracer studies, enabling improved preclinical evaluation of colon-targeted imaging agents.

• In Vitro Drug Response Evaluation: Distinguishing Proliferat

  2026-05-10

  Schwartz's dissertation introduces a rigorous framework for distinguishing between drug-induced proliferation arrest and cell death in cancer models using in vitro assessment. This distinction enables more precise evaluation of apoptosis induction and drug efficacy, improving experimental interpretation for oncology research.

• PD 173074: Strategic FGFR1 Inhibition for Translational Impa

  2026-05-09

  This thought-leadership article explores how PD 173074, a benchmark FGFR1/VEGFR2 inhibitor from APExBIO, enables translational researchers to interrogate the fundamental mechanisms of adipogenesis, angiogenesis, and cancer progression. By integrating mechanistic insights with protocol guidance and strategic recommendations, it provides an evidence-based roadmap for optimizing experimental design and bridging preclinical findings to clinical innovation.

• Practical Use of Prestained Protein Marker (Triple Color, ED

  2026-05-09

  The Prestained Protein Marker (Triple color, EDTA free, 10-250 kDa) enables accurate, visible monitoring of protein separation and Western blot transfer across a broad molecular weight range. Its triple-color, EDTA-free design is suited for workflows demanding compatibility with phosphoprotein analysis and fluorescent imaging. It is not intended for protein quantification or use outside the 10-250 kDa range.

• AO/PI Double Staining Kit: Practical Guide for Cell Viabilit

  2026-05-08

  The AO/PI Double Staining Kit enables researchers to discriminate viable, apoptotic, and necrotic cells in a single workflow using dual fluorescent dyes. It is best suited for cell viability, apoptosis, and necrosis detection in cell biology experiments, but should not be used where membrane integrity is not relevant to the cell death pathway under study.

• hiPSC-Derived Sensory Neurons as a Model for HSV-1 Latency

  2026-05-07

  This study establishes a robust, scalable protocol for differentiating human inducible pluripotent stem cells (hiPSCs) into mature sensory neurons, enabling detailed modeling of latent infection and reactivation of herpes simplex virus 1 (HSV-1). These advancements offer a human-relevant system to investigate latency mechanisms previously inaccessible with animal models, with meaningful implications for antiviral research and therapeutic strategy development.

• Reliable PTEN Restoration with EZ Cap™ Human PTEN mRNA (SKU

  2026-05-07

  This article explores how EZ Cap™ Human PTEN mRNA (SKU R1025) addresses reproducibility, sensitivity, and workflow challenges in tumor suppressor gene mRNA research. Scenario-driven Q&A blocks highlight its Cap 1 structure, poly(A) tail, and validated performance for cancer and gene therapy research.

• QPRT Drives Breast Cancer Invasion via PLC-Dependent Pathway

  2026-05-06

  This study reveals that quinolinate phosphoribosyltransferase (QPRT) enhances breast cancer invasiveness by facilitating myosin light chain phosphorylation through a pathway involving phospholipase C (PLC) signaling. The findings highlight a mechanistic link between NAD+ biosynthesis and cytoskeletal regulation, providing a new angle for targeted intervention in aggressive breast cancer phenotypes.

• 5-Methyl-CTP: Structural Innovations for mRNA Vaccine Design

  2026-05-06

  Explore how 5-Methyl-CTP enhances mRNA vaccine engineering by improving stability and translation efficiency. This article examines the nucleotide’s critical role in advanced delivery platforms and provides new scientific insights beyond standard workflow guidance.

• Azithromycin in Bacterial Resistance: From Mechanism to Mode

  2026-05-05

  Explore the advanced role of Azithromycin in bacterial infection research, focusing on resistance trends and translational model design. This article uniquely connects molecular mechanism with evolving experimental strategies for macrolide antibiotics.

• MK-0812: Precision Monocyte Trafficking Inhibition for Infla

  2026-05-05

  MK-0812 stands out as a highly selective CCR2 antagonist, enabling reproducible inhibition of monocyte recruitment in both in vitro and in vivo inflammation models. Its robust performance in MCP-1 signaling blockade and validated protocol parameters make it indispensable for dissecting immune mechanisms in metabolic and inflammatory disease research.

• Rosiglitazone (Brl-49653): Advanced Insights for Rare Metabo

  2026-05-04

  Explore the multifaceted actions of Rosiglitazone in metabolic disease research, including its role in rare monogenic lipodystrophies and advanced PPARγ pathway interrogation. This article provides deep scientific context and actionable protocol guidance for investigators.

• High-Throughput MoA Mapping Reveals Novel M. tuberculosis DH

  2026-05-04

  This study presents a machine learning-driven framework that integrates phenotypic and biophysical high-throughput screening to identify mechanisms of action and novel inhibitors against Mycobacterium tuberculosis, specifically targeting dihydrofolate reductase (DHFR). The approach addresses key limitations in antibacterial discovery and offers a robust path for prioritizing compounds with true in vivo efficacy.

• Gepotidacin in Antibacterial Research: Protocols and Innovat

  2026-05-03

  Gepotidacin (GSK2140944) provides a unique, dual-targeted mechanism against resistant bacteria, enabling advanced antibacterial research. This guide details experimental workflows, troubleshooting, and protocol optimization to harness Gepotidacin’s full potential in bacterial DNA replication inhibition studies.

• Gepotidacin Pharmacokinetics and Safety Across Age Groups

  2026-05-02

  This phase I study evaluates the pharmacokinetics, safety, and tolerability of gepotidacin (GSK2140944), a novel bacterial DNA replication inhibitor, in both healthy adults and elderly subjects. The findings demonstrate dose-proportional pharmacokinetics, time-invariant steady-state, and favorable tolerability across a broad dosing range, supporting further clinical research in antibiotic resistance.

442 records 18/30 page Previous Next First page 上5页 1617181920 下5页 Last page